Athena Vale
Cirrhosis of the liver is a late-stage liver disease that causes permanent scarring and damage to the liver, interfering with its functioning. Muscle cirrhosis is associated with muscle wasting, malnutrition, and sarcopenia, which is the progressive and generalized loss of muscle mass. Muscle depletion is a common feature of cirrhosis, found in about 40% of patients, and is considered a major complication of end-stage liver disease. It is caused by reduced nutrient intake, dietary restrictions, and intestinal malabsorption, leading to decreased functional capacity and a higher risk of mortality.
| Characteristics | Values |
|---|---|
| Definition | Permanent scarring from long-term liver disease |
| Cause | Alcohol and drugs, viruses, metabolic factors |
| Mechanism | Blocks blood and oxygen flow through liver tissues, reducing liver function |
| Complications | Liver failure, sepsis |
| Diagnosis | CT scans, MRI, BIA, DXA, ultrasound |
| Treatment | Nutritional support, exercise, targeted therapies |
| Associated conditions | Sarcopenia, malnutrition, cachexia |
Explore related products
What You'll Learn
Muscle wasting and malnutrition
Cirrhosis of the liver is a late-stage liver disease that results from persistent liver damage over many years. It is characterised by permanent scarring that damages liver function and interferes with blood and oxygen flow. As cirrhosis progresses, it can lead to liver failure and various complications that increase the risk of short-term mortality.
Muscle wasting, or sarcopenia, is one such complication that negatively impacts survival, quality of life, and response to stressors such as infection and surgery in patients with cirrhosis. It is defined as the progressive and generalised loss of muscle mass, which can be assessed through cross-sectional imaging studies like CT scans. Sarcopenia is present in approximately 40% of patients with cirrhosis and is associated with physical inactivity and low dietary intake.
Malnutrition is also a common feature of cirrhosis, affecting about 20% of patients with compensated cirrhosis and 50% of those with decompensated cirrhosis. It is characterised by an imbalance of nutrients, leading to adverse effects on body composition and function. Malnutrition can manifest as frailty and/or sarcopenia, with loss of muscle mass. Nutritional interventions and exercise may help correct muscle depletion and improve survival, but further research is needed.
The development of sarcopenia and frailty in patients with cirrhosis can be influenced by various factors. Reduced nutrient intake is common, often due to dietary restrictions in sodium and water, or decreased appetite caused by increased leptin and pro-inflammatory cytokine levels. Additionally, nausea and early satiety related to tense ascites, gastroparesis, or small bowel dismotility can contribute to poor nutrient intake. Intestinal absorption may also be reduced due to maldigestion caused by pancreatic insufficiency, drug-related diarrhoea, or intestinal bacterial overgrowth.
The underlying pathology of cirrhosis can further contribute to malnutrition and muscle wasting through chronic inflammation, altered protein metabolism, impaired myotoxic ammonia, and disease-specific concerns such as alcohol exposure and insulin resistance. These factors collectively impact muscle function and increase the risk of adverse clinical outcomes.
The Powerful Muscles that Control Our Eyesight
You may want to see also
Explore related products
Causes of cirrhosis
Cirrhosis is a slowly progressing disease characterized by the replacement of healthy liver tissue with scar tissue, leading to liver failure and complications such as muscle wasting, hence the term "muscle cirrhosis." This condition develops silently over years or even decades, and its causes can be grouped into several categories.
One of the most common causes of cirrhosis is excessive alcohol consumption, which leads to alcoholic liver disease. Alcoholic liver disease progresses in stages, beginning with fatty liver, progressing to alcoholic hepatitis, and eventually leading to cirrhosis if alcohol consumption continues. The risk of developing cirrhosis increases with the amount and duration of alcohol consumption.
Another cause is non-alcoholic fatty liver disease (NAFLD), which is closely linked to metabolic syndrome and insulin resistance. NAFLD is characterized by excessive fat accumulation in the liver, which can progress to inflammation (non-alcoholic steatohepatitis or NASH) and eventually cirrhosis. Obesity, type 2 diabetes, and high cholesterol are all risk factors for NAFLD.
Hepatitis B and C virus infections are also major causes of cirrhosis worldwide. Chronic inflammation of the liver due to these viruses can lead to liver cell damage and fibrosis, which can progress to cirrhosis over time. Other less common infectious causes include hepatitis A, D, and E viruses, as well as parasitic infections.
Additionally, certain genetic or autoimmune disorders can cause cirrhosis. Hereditary hemochromatosis, for example, leads to excessive iron absorption and accumulation in the liver, which can result in cirrhosis if left untreated. Autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis are autoimmune disorders that can cause chronic liver inflammation and lead to cirrhosis.
Finally, certain medications, toxins, and environmental factors can contribute to the development of cirrhosis. Long-term use of certain drugs, such as methotrexate or amiodarone, can cause drug-induced liver disease, leading to cirrhosis. Exposure to toxins like aflatoxin (produced by mold) or excessive consumption of acetaminophen (paracetamol) can also damage the liver and contribute to cirrhosis.
Explore Your ER Muscle: Powering Your Emotional Resilience
You may want to see also
Explore related products
Diagnosis and treatment
Cirrhosis of the liver is permanent scarring that results from persistent liver damage over many years. It damages the liver and interferes with its functioning, and can lead to liver failure. Alcohol and drugs, viruses, and metabolic factors are the most common causes.
The initial diagnosis of cirrhosis involves viral hepatitis serologies, ferritin, transferrin saturation, and abdominal ultrasonography, as well as a complete blood count, liver function tests, and prothrombin time/international normalized ratio, if these have not already been ordered. Additional tests are based on the patient's demographics and risk factors.
Serum and ultrasound-based screening tests to assess fibrosis include the aspartate transaminase-to-platelet ratio index score, Fibrosis 4 score, FibroTest/FibroSure, nonalcoholic fatty liver fibrosis score, standard ultrasonography, and transient elastography. Non-invasive tests are most useful in identifying patients with no to minimal fibrosis or advanced fibrosis.
Chronic liver disease management includes directed counseling, laboratory testing, and ultrasound monitoring. Treatment goals are preventing cirrhosis, decompensation, and death.
If the cirrhosis is caused by toxic or alcohol-related liver disease, eliminating those toxins from your life is the only treatment. This may involve treatment for a substance use disorder. Managing metabolic factors like cholesterol, blood sugar, and weight can help relieve non-alcohol-related liver disease. Eliminating alcohol and drugs that damage the liver will help preserve it for longer, even if the disease is caused by other factors.
Healthcare providers recommend that anyone with any type of liver disease should try to maintain a healthy diet and achieve a healthy weight. In addition, some people might need dietary supplements to treat nutritional deficiencies.
Muscle wasting, or sarcopenia, is a common feature of cirrhosis, found in approximately 40% of patients. It is defined as a muscle mass 2 standard deviations below the healthy young adult mean. It is associated with a decreased functional capacity and a higher risk of mortality. The use of CT scans to assess muscle size is inappropriate for routine clinical practice, and alternative tools are being developed. Nutritional interventions and exercise may improve muscle wasting and survival rates, but further research is needed.
Targeted Training: Rows for a Powerful Back
You may want to see also
Explore related products
Progression of the disease
Cirrhosis of the liver is a progressive condition that causes permanent scarring of the liver, interfering with its functioning. It is a late-stage liver disease that develops over many years and can lead to liver failure. While the liver generally has strong healing abilities, cirrhosis reaches a stage where there are not enough healthy cells left for the liver to heal itself.
In the initial stages of cirrhosis, the body compensates for the reduced liver function, and symptoms may not be noticeable. This is referred to as compensated cirrhosis. However, as the condition progresses, liver damage accumulates, and the liver function continues to decline. This stage is called decompensated cirrhosis, and it is marked by noticeable symptoms.
The progression of cirrhosis involves the development of scar tissue, which blocks the flow of blood and oxygen through the liver tissues. This impairs the liver's ability to process blood, metabolize nutrients, and eliminate toxins. Additionally, cirrhosis hinders the liver's capacity to produce essential blood proteins and bile. The scar tissue can also compress blood vessels, including the crucial portal vein system, resulting in portal hypertension.
As cirrhosis advances, muscle wasting becomes a common complication, affecting approximately 40% of patients. It is characterised by a progressive and generalised loss of muscle mass, which is associated with a higher risk of mortality. Sarcopenia, defined as a muscle mass significantly below the average of a healthy young adult, is observed in patients with cirrhosis. Nutritional interventions and exercise may potentially improve muscle wasting and survival, but further research is needed.
The impact of muscle wasting on survival in patients with cirrhosis is significant. Studies have found that decreased muscle size, as assessed by CT scans, is an independent predictor of mortality. Muscle wasting is also associated with malnutrition, which further contributes to muscle depletion. The prevalence of muscle wasting increases with the progression of cirrhosis, making it a critical factor in the disease's advancement and patient prognosis.
Muscle Shoals River: Where is this Historic River?
You may want to see also
Explore related products
Complications and mortality
Cirrhosis of the liver is a late-stage liver disease that causes permanent scarring of the liver, interfering with its functioning. It is the result of persistent liver damage over many years, with causes ranging from alcohol and drug use to viruses and metabolic factors. As cirrhosis progresses, the liver's function declines, and blood and oxygen flow through the liver tissues is blocked. This slows the liver's ability to process blood, metabolize nutrients, and filter out toxins.
Cirrhosis of the liver can lead to a range of complications, including:
- Ascites: Swelling in the abdomen due to portal hypertension.
- Hepatic Encephalopathy: Confusion, disorientation, and mood changes caused by liver dysfunction.
- Variceal Bleeding: Bleeding from enlarged veins in the esophagus or stomach due to increased pressure in the portal vein.
- Kidney Dysfunction: Reduced kidney function, which can lead to chronic kidney failure and low urine output.
- Hepatocellular Carcinoma: Primary liver cancer, which is a possible complication of cirrhosis.
- Malnutrition and Muscle Wasting (Sarcopenia): Malnutrition and sarcopenia are common in cirrhosis and negatively impact survival, quality of life, and response to stressors. Sarcopenia is defined as a muscle mass significantly below the healthy adult mean and is associated with aging and chronic diseases. It leads to decreased functional capacity and a higher risk of mortality.
The development of these complications, especially ascites, encephalopathy, and sarcopenia, indicates an increasing risk of short-term mortality in patients with cirrhosis. The presence of sarcopenia is independently associated with higher mortality risks, and patients with sarcopenia have a significantly lower median survival time compared to those without.
The impact of muscle wasting on survival in patients with cirrhosis highlights the potential for nutritional interventions and exercise to improve muscle depletion and, subsequently, patient outcomes. While the exact mechanisms contributing to muscle wasting in cirrhosis are multifactorial, they often include reduced nutrient intake due to dietary restrictions, decreased taste sensation, and nausea. Additionally, intestinal absorption may be impaired due to maldigestion, drug-related diarrhea, or intestinal bacterial overgrowth.
Testing Muscle Fibers: A Comprehensive Guide
You may want to see also
